Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
FogPharma
FogPharma develops cell-penetrating mini proteins to treat cancer.
Sector
Subsector
Keywords
Location
total rounds
total raised
Arrakis Therapeutics
Arrakis Therapeutics develops drugs to treat neurological disorders and other diseases using a drug discovery platform that targets RNA.
Sector
Subsector
Keywords
Location
total rounds
total raised
Triana Biomedicines
Triana Biomedicines develops a molecular glue discovery platform to regulate disease.
Sector
Subsector
Location
total rounds
total raised
Mersana Therapeutics
Mersana Therapeutics develops a biodegradable polymer platform to create new and better medicines.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 25.06.2024. Their latest investor ArrowMark Partners. Their latest round Series C
Droia Ventures
Droia is a biotech investor that invests exclusively in oncology and genetic disease therapies.
Sector
Subsector
Location
count Of Investments
Deerfield Management
Deerfield Management is a healthcare company that focuses on advancing healthcare through investment, information, and philanthropy.
Sector
Subsector
Keywords
count Of Investments
Woodline Partners
Woodline Partners is a San Francisco-based investment firm specializing in healthcare and technology sectors.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors12
Number of lead investors
Number of investors
ArrowMark Partners
ArrowMark Partners is an employee-owned asset management firm founded in 2007.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Deep Track Capital
Deep Track Capital is a Greenwich-based investment firm focused on life sciences.
Sector
Subsector
Location
count Of Investments
count Of Exists
DCVC Bio
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders1
Chris Varma
Chris joined Flagship in 2007 as Partner and focuses primarily on Life Science investments. He came to Flagship with significant management experience in clinical development, regulatory strategy, business development, sales, and marketing in the pharmaceutical industry. Prior to Flagship, Chris was with Novartis Pharmaceuticals since 2004 where he served most recently as Director of the Tekturna (aliskiren) marketing team responsible for all Medical Marketing, Medical Strategy, and Professional Promotions activities in the U.S. Chris also oversaw Tekturna�s extensive clinical development programs, and played a key role in the FDA approval, CMS reimbursement coverage approval, and successful commercial launch of Tekturna in early 2007. Previously at Novartis, Chris was Director of Business Development & Licensing where he identified several in-licensing opportunities and drove key transactions. Prior to that, Chris focused on corporate strategy working directly with the Novartis Pharma CEO in Basel, Switzerland. Before Novartis, Chris was a consultant for Millennium Pharmaceuticals working on special projects in the Personalized Medicine Group. Before Millennium, Chris worked for the US Food and Drug Administration (FDA) in the Office of Combination Products coordinating and managing reviews across the major Centers. Early in his career he co-founded Epitrope Corporation, a company that developed server-side solutions for wireless telecom carriers.
current job
Chris Varma